| Lisa F Stanken, MD | |
|
4440 Red Bank Rd Ste 110, Cincinnati, OH 45227-2177 | |
| (513) 564-1366 | |
| (513) 564-1367 |
| Full Name | Lisa F Stanken |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 27 Years |
| Location | 4440 Red Bank Rd Ste 110, Cincinnati, Ohio |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023008232 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 35900 (Kentucky) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Christ Hospital | Cincinnati, OH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| The Christ Hospital Health Network Urgent Care, Llc | 9931388246 | 16 |
| The Christ Hospital Health Network Urgent Care, Llc | 9931388246 | 16 |
News Archive
Despite ongoing efforts to educate the public about HIV, a new study by researchers from UCLA, the RAND Corp., Harvard University and Children's Hospital Boston has found that two-thirds of families with an HIV-infected parent experience fears about spreading HIV in the home.
S*BIO Pte Ltd today announced a US$5 million investment by Mitsui Ventures that will support the continued development of S*BIO's clinical programs.
Compared with erlotinib, treatment with afatinib leads to outcomes in previously treated patients with advanced squamous non-small-cell lung cancer, suggest the results of a head-to-head trial.
Previous studies have shown that Yizhijiannao granule can enhance cognitive performance in Alzheimer's disease patients and Alzheimer's disease-model mice.
Genzyme Corp. announced today that ongoing discussions with Sanofi-Aventis have progressed to the point where Genzyme's board has authorized the company to enter into a confidentiality agreement with Sanofi-Aventis in order to allow Sanofi to conduct due diligence. Discussions between Genzyme's advisors and Sanofi's advisors and between Genzyme and Sanofi representatives are continuing.
› Verified 5 days ago
| Entity Name | Lifestyle Resumption Integrative Health |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1962444653 PECOS PAC ID: 9830159680 Enrollment ID: O20041015000269 |
News Archive
Despite ongoing efforts to educate the public about HIV, a new study by researchers from UCLA, the RAND Corp., Harvard University and Children's Hospital Boston has found that two-thirds of families with an HIV-infected parent experience fears about spreading HIV in the home.
S*BIO Pte Ltd today announced a US$5 million investment by Mitsui Ventures that will support the continued development of S*BIO's clinical programs.
Compared with erlotinib, treatment with afatinib leads to outcomes in previously treated patients with advanced squamous non-small-cell lung cancer, suggest the results of a head-to-head trial.
Previous studies have shown that Yizhijiannao granule can enhance cognitive performance in Alzheimer's disease patients and Alzheimer's disease-model mice.
Genzyme Corp. announced today that ongoing discussions with Sanofi-Aventis have progressed to the point where Genzyme's board has authorized the company to enter into a confidentiality agreement with Sanofi-Aventis in order to allow Sanofi to conduct due diligence. Discussions between Genzyme's advisors and Sanofi's advisors and between Genzyme and Sanofi representatives are continuing.
› Verified 5 days ago
| Entity Name | The Christ Hospital Health Network Urgent Care, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477867208 PECOS PAC ID: 9931388246 Enrollment ID: O20180202001601 |
News Archive
Despite ongoing efforts to educate the public about HIV, a new study by researchers from UCLA, the RAND Corp., Harvard University and Children's Hospital Boston has found that two-thirds of families with an HIV-infected parent experience fears about spreading HIV in the home.
S*BIO Pte Ltd today announced a US$5 million investment by Mitsui Ventures that will support the continued development of S*BIO's clinical programs.
Compared with erlotinib, treatment with afatinib leads to outcomes in previously treated patients with advanced squamous non-small-cell lung cancer, suggest the results of a head-to-head trial.
Previous studies have shown that Yizhijiannao granule can enhance cognitive performance in Alzheimer's disease patients and Alzheimer's disease-model mice.
Genzyme Corp. announced today that ongoing discussions with Sanofi-Aventis have progressed to the point where Genzyme's board has authorized the company to enter into a confidentiality agreement with Sanofi-Aventis in order to allow Sanofi to conduct due diligence. Discussions between Genzyme's advisors and Sanofi's advisors and between Genzyme and Sanofi representatives are continuing.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Lisa F Stanken, MD 935 State Route 28, Milford, OH 45150-1957 Ph: (513) 831-5955 | Lisa F Stanken, MD 4440 Red Bank Rd Ste 110, Cincinnati, OH 45227-2177 Ph: (513) 564-1366 |
News Archive
Despite ongoing efforts to educate the public about HIV, a new study by researchers from UCLA, the RAND Corp., Harvard University and Children's Hospital Boston has found that two-thirds of families with an HIV-infected parent experience fears about spreading HIV in the home.
S*BIO Pte Ltd today announced a US$5 million investment by Mitsui Ventures that will support the continued development of S*BIO's clinical programs.
Compared with erlotinib, treatment with afatinib leads to outcomes in previously treated patients with advanced squamous non-small-cell lung cancer, suggest the results of a head-to-head trial.
Previous studies have shown that Yizhijiannao granule can enhance cognitive performance in Alzheimer's disease patients and Alzheimer's disease-model mice.
Genzyme Corp. announced today that ongoing discussions with Sanofi-Aventis have progressed to the point where Genzyme's board has authorized the company to enter into a confidentiality agreement with Sanofi-Aventis in order to allow Sanofi to conduct due diligence. Discussions between Genzyme's advisors and Sanofi's advisors and between Genzyme and Sanofi representatives are continuing.
› Verified 5 days ago
Dr. David Hayes, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 6825 Wooster Pike, Cincinnati, OH 45227 Phone: 513-272-0250 Fax: 513-272-1278 | |
Mrs. Magdelene Kay May, DO Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 7500 State Rd, Cincinnati, OH 45255 Phone: 513-624-4500 | |
Donald R Williams, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 473 Old State Route 74, Suite 4, Cincinnati, OH 45244 Phone: 513-528-1505 Fax: 513-528-5982 | |
Dr. Usha R Shenai, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 10196 Springfield Pike, Cincinnati, OH 45215 Phone: 513-771-0800 Fax: 513-771-0803 | |
Dr. Reid Arthur Hartmann, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2123 Auburn Ave, Suite 235, Cincinnati, OH 45219 Phone: 513-585-3238 Fax: 513-585-3254 | |
Lee E Niemeyer Ii, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 379 Dixmyth Ave, Cincinnati, OH 45220 Phone: 513-246-7000 Fax: 513-246-7590 | |
Richard J Sanders, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3645 Stonecreek Blvd Unit D, Cincinnati, OH 45251 Phone: 513-923-2300 |